Parents say 'we're the reason' Galway daughter inherited rare fatal disease


She may not live beyond 40 according to doctors
The parents of Aoife Quinn, a young Galway woman living with a rare fatal disease, have said ‘we’re the reason’ that she’s living with it.
The Oranmore woman who was diagnosed with Friedreich's Ataxia may not live beyond 40-years-old according to doctors.
Aoife was diagnosed with the rare genetic neurological disease at the age of 18, a disease that causes difficulty walking, slurred speech and heart problems.
She is calling on the HSE and government to approve the treatment omaveloxolone, also known as Skyclarys, which could extend her life expectancy.
Despite her parents’ Donal and Angela’s heartbreaking admission, Aoife says that “there is no one to blame” adding that her mam and dad “didn’t know they were carriers of the gene” and is calling on the HSE and the government to roll out a life-changing drug as quickly as possible.
.png?trim=94,0,67,0&width=640&quality=65)

In a video, uploaded by Aoife to her social media, her dad Donal said: “We’re Aoife’s mum and dad - we’re also the reason that Aoife has FA.
“We’ve watched Aoife steadily decline, from a time where she was playing camogie with our local club, to now where she needs assistance with her walk.
“Aoife will lose her walk, her talk, her balance. She will lose her sight, her hearing and she will lose her swallow.
“There is a drug called Skyclarys, which will slow down the progression of this disease. However, the HSE would prefer to see Aoife and the 200 sufferers and their families continue to suffer instead of reimbursing this drug.
“The HSE don’t think that our beautiful Aoife is worth the money. But, we do. And we think that the other sufferers and their families are worth the money as well.”
Donal finished by saying: “This drug gives each of them and their families a glimmer of hope.”
Her mother Angela continued strongly by saying: “Donal and I stand with Aoife, and all the FA community. We are pleading with the Government to stand with Aoife and the others and to overrule the HSE decision.
“Skyclarys can improve their quality of life and give them hope but time is not on their side. Together, we can get this over the line.”
Posting this to social media, Aoife added: “This is my mum and dad, as they don’t use social media they asked me to post this.
“There is no one to blame. My parents didn’t know they were carriers, and being a carrier isn’t something they chose. It’s because I inherited an altered FXN gene from both of them. This is just how recessive genetic inheritance can work.”
Aoife told Kieran Cuddihy on Liveline back in May: “People have died from this, it’s awful. I’m blessed that at the age of 23 I’m still walking.”
“My speech is grand, my sight and hearing is grand but like that it is just a matter of time before my body starts to deteriorate,” Aoife said on Liveline.
Aoife said that she hopes that the new drug, omaveloxolone, which is currently in negotiations will be rolled out in Ireland.
“But between then and now there are people all over the country that are losing the ability to walk and talk. I am really really praying that it comes so I can keep my ability to walk,” Aoife said on Liveline.
“I need as many TDs on my side and patients with Friedreich’s across the country to get these negotiations between Biogen and the HSE done as quickly as possible. Time is not on our side,” Aoife said on Liveline.
